THCV Can Either Mimic or Block THC Effects in Rats Depending on Dose

THCV produced an inverted U-shaped response curve in THC-trained rats. At 3 mg/kg, it partially substituted for THC (54.6%). At 6 mg/kg, it reversed THC-induced responding. Blood THC levels were unchanged when combined with THCV, confirming the interaction is pharmacological rather than pharmacokinetic.

Drug discrimination study in 16 male Sprague-Dawley rats trained to distinguish THC (3 mg/kg) from vehicle under a fixed ratio 20 schedule. Tested THCV alone and in combination with THC, with blood cannabinoid level measurements.

THCV is increasingly marketed as a distinct cannabinoid, but its pharmacology is complex. This study demonstrates it can act like THC or oppose THC depending on dose, which has real implications for consumers and product formulators.

As cannabis products increasingly feature specific cannabinoid profiles, understanding how minor cannabinoids like THCV interact with THC is critical. A compound that can both mimic and block THC depending on dose challenges simple marketing claims about THCV effects.

Animal study using only male rats, limiting generalizability to humans and across sexes. Drug discrimination is a behavioral proxy, not a direct measure of subjective effects. Dose ranges may not translate directly to human consumption.